Schroders Capital Global Innovation positions portfolio for buybacks as NAV slumps 13%

Schroders Capital Global Innovation's discount widened in H1 and performance was hit by losses from legacy holdings.

Related Keywords

Tim Edwards ,Oxford Nanopore ,Association Of Investment Companies ,Johnson Matthey ,Spirent Communications ,Woodford Patient Capital ,Schroder United Kingdom Public Private ,Investment Companies ,Petershill Partners ,Indian Agri Tech ,Carmot Therapeutics ,Oxford Nanopore Technologies ,Amo Pharma ,Hav ,Nov ,Enevolent Ai ,F1 2023 ,